Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors

NCT02156388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Neutropenia
Metastatic Tumors

Interventions

BIOLOGICAL: GW003

Sponsor

Jiangsu T-Mab Biopharma Co.,Ltd